Evidence map›Paper›PMID 41827778›Full record

ArticleCancers2026

Distinct NK Cell Signatures Define Prognosis in HPV-Positive Versus HPV-Negative Head and Neck Cancer.

Rui Li, Fangjia Tong, Huan Liu, Zengchen Liu, Wanlin Li, Yingdong Zhang, Yiman Peng, Shuang Pan, Lanlan Wei, Ning Li and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rui LiDepartment of Neurosurgery, Shenzhen Third People's Hospital, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, China.ORCID 0009-0000-1860-0379
Fangjia TongNational Clinical Research Center for Infectious Diseases, Institute for Hepatology, The Third People's Hospital of Shenzhen, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, China.
Huan LiuNational Clinical Research Center for Infectious Diseases, Institute for Hepatology, The Third People's Hospital of Shenzhen, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, China.
Zengchen LiuDepartment of Neurosurgery, Shenzhen Third People's Hospital, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, China.
Wanlin LiNational Clinical Research Center for Infectious Diseases, Institute for Hepatology, The Third People's Hospital of Shenzhen, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, China.
Yingdong ZhangNational Clinical Research Center for Infectious Diseases, Institute for Hepatology, The Third People's Hospital of Shenzhen, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, China.ORCID 0009-0008-1744-2362
Yiman PengNational Clinical Research Center for Infectious Diseases, Institute for Hepatology, The Third People's Hospital of Shenzhen, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, China.
Shuang PanThe First Affiliated Hospital of Harbin Medical University and Department of Endodontics, School of Stomatology, Harbin Medical University, Harbin 150001, China.
Lanlan WeiNational Clinical Research Center for Infectious Diseases, Institute for Hepatology, The Third People's Hospital of Shenzhen, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, China.
Ning LiBiotherapy Clinical Research Center, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, China.ORCID 0000-0003-1983-3806
Ming ChuDepartment of Neurosurgery, Shenzhen Third People's Hospital, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, China.

Funding

the Guangdong Provincial Basic and Applied Basic Research Foundation 2023A1515220104the National Natural Science Foundation of China 82473326the Shenzhen Basic Research Program JCYJ20210324114009026the Shenzhen Basic Research Program (Natural Science Foundation) 20240808155554004 and 20240813101801002)the Shenzhen Special Funds for Strategic Emerging Industries F-2022-Z99-502266the Shenzhen University High-Level Clinical Specialty Construction Project-Enhancement Program for the Shenzhen Neurosurgery Specialist Training Pilot Base LCXKB202415
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

head and neck cancerhuman papillomavirusimmunotherapynatural killer cellstumor microenvironment

Identifiers

PMID41827778
PMCPMC12984458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.